YUHAN CORPORATION

000100 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩79,400.00
+0.63%
Delayed · cached 15 min

Fair value analysis

000100
YUHAN CORPORATION
PharmaceuticalsPharmaceuticals
₩79,400.00
Close used for this calculation
₩56,812.61Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
53/100
Profitability19/25
Returns3/25
Balance Sheet21/25
Efficiency10/25
Growth12/25
Good
Quality radar
53Prof.19/25Ret.3/25Eff.10/25B.Sht21/25Growth12/25

Consensus fair value

₩56,812.61
Above FV
▼ -28.4% against the close used
Model range ₩1,844.56 – ₩168,068.67
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩1,844.56Fair value₩56,812.61Bull₩168,068.67
FairClose
52-week traded range
52W low ₩66,400.0052W high ₩125,000.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

YUHAN CORPORATION closed at ₩79,400.00, 39.8% above the consensus fair value of ₩56,812.61 drawn from 9 valuation models.

Financial DNA score 53/100 — Good. P/E of 30.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩1,844.56
-97.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩43,356.70
-45.4%
√(22.5 × EPS × BVPS)
EPS=2599, BVPS=32145.75 · outside Graham range (P/E 30.6, P/B 2.5) — asset-light, treat as a rough floor
Graham Formula
₩168,068.67
+111.7%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩51,980.00
-34.5%
EPS × 20x (sector P/E)
EPS=2599, Sector P/E=20x
Peter Lynch (PEG)
₩77,970.00
-1.8%
EPS × Growth% (PEG = 1 is fair)
EPS=2599, g=30%
EV/EBITDA
₩34,415.22
-56.7%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=154.04B
Book Value (P/B)
₩17,840.89
-77.5%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=32145.75, ROE=8.2%, g=6%, r=10%
Reverse DCF
₩79,400.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 12.9% | Historical: 31%
Margin of Safety
₩49,734.36
-37.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=66312.48, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.